| DK04789575.0TDK1678194T3 (en) | 2003-10-10 | 2004-10-11 | MODULATING SYNTHESIS AND DEGRADING HYALURONANE IN THE TREATMENT OF DISEASE |
| NZ546272ANZ546272A (en) | 2003-10-10 | 2004-10-11 | The modulation of hyaluronan synthesis and degradation in the treatment of disease |
| US10/574,903US7662929B2 (en) | 2003-10-10 | 2004-10-11 | Antibody that specifically binds hyaluronan synthase |
| SI200432088TSI1678194T1 (en) | 2003-10-10 | 2004-10-11 | The modulation of hyaluronan synthesis and degradation in the treatment of disease |
| PT47895750TPT1678194E (en) | 2003-10-10 | 2004-10-11 | The modulation of hyaluronan synthesis and degradation in the treatment of disease |
| EP04789575.0AEP1678194B1 (en) | 2003-10-10 | 2004-10-11 | The modulation of hyaluronan synthesis and degradation in the treatment of disease |
| AU2004279475AAU2004279475B2 (en) | 2003-10-10 | 2004-10-11 | The moduilation of hyaluronan synthesis and degradation in the treatment of disease |
| CN2004800341053ACN1882602B (en) | 2003-10-10 | 2004-10-11 | Regulation of hyaluronan synthesis and degradation in disease therapy |
| JP2006529463AJP2007507430A (en) | 2003-10-10 | 2004-10-11 | Modulation of hyaluronan synthesis and degradation in the treatment of disease |
| CA2541438ACA2541438C (en) | 2003-10-10 | 2004-10-11 | The modulation of hyaluronan synthesis and degradation in the treatment of disease |
| ES04789575.0TES2437491T3 (en) | 2003-10-10 | 2004-10-11 | Modulation of the synthesis and degradation of hyaluronan in the treatment of disease |
| PL04789575TPL1678194T3 (en) | 2003-10-10 | 2004-10-11 | The modulation of hyaluronan synthesis and degradation in the treatment of disease |
| PCT/AU2004/001383WO2005035548A1 (en) | 2003-10-10 | 2004-10-11 | The moduilation of hyaluronan synthesis and degradation in the treatment of disease |
| US12/638,803US7985844B2 (en) | 2003-10-10 | 2009-12-15 | Antibody that specifically binds hyaluronan synthase |
| US13/159,015US8460658B2 (en) | 2003-10-10 | 2011-06-13 | Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |